371 related articles for article (PubMed ID: 32010931)
41. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
Zeng J; Zeng Q
Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
[TBL] [Abstract][Full Text] [Related]
42. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
43. Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis.
Luo Z; Lu Z; Muhammad I; Chen Y; Chen Q; Zhang J; Song Y
Lipids Health Dis; 2018 Aug; 17(1):191. PubMed ID: 30115070
[TBL] [Abstract][Full Text] [Related]
44. Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.
Rai V
Metab Brain Dis; 2016 Aug; 31(4):727-35. PubMed ID: 26956130
[TBL] [Abstract][Full Text] [Related]
45. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
46. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: a pooled analysis of 83 studies with 74,019 participants.
Zhang Y; Jia H; Wang S; Jiang D
Minerva Med; 2017 Feb; 108(1):57-73. PubMed ID: 27824246
[TBL] [Abstract][Full Text] [Related]
47. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
[TBL] [Abstract][Full Text] [Related]
48. [Effects of methylenetetrahydrofolate reductase gene polymorphism and long-term exposure to organophosphorus pesticides on type 2 diabetes mellitus].
Dong Y; Li W; Wang T; Miao J; Li T; Zhou Y
Wei Sheng Yan Jiu; 2019 Jul; 48(4):621-627. PubMed ID: 31601346
[TBL] [Abstract][Full Text] [Related]
49. Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
Carvalho SCR; Vasconcelos LRS; Fonseca LD; Carmo RF; Tomitão MT; Aroucha DCBL; Pereira LMMB; Stefano JT; Ribeiro-Júnior U; Oliveira CP; Carrilho FJ
Clinics (Sao Paulo); 2021; 76():e2881. PubMed ID: 34644732
[TBL] [Abstract][Full Text] [Related]
50. Association Between MTHFR C677T Polymorphism and Congenital Heart Disease.
Liu PF; Ding B; Zhang JY; Mei XF; Li F; Wu P; Mei CH; Zhou YF; Chen T
Int Heart J; 2020 May; 61(3):553-561. PubMed ID: 32418960
[TBL] [Abstract][Full Text] [Related]
51. Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.
Li SY; Ye JY; Liang EY; Zhou LX; Yang M
Med Sci Monit; 2015 Mar; 21():740-8. PubMed ID: 25761797
[TBL] [Abstract][Full Text] [Related]
52. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
53. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.
Zhu B; Wu X; Zhi X; Liu L; Zheng Q; Sun G
PLoS One; 2014; 9(7):e102443. PubMed ID: 25047451
[TBL] [Abstract][Full Text] [Related]
54. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and peripheral arterial disease: A meta-analysis.
Liu F; Du J; Nie M; Fu J; Sun J
Vascular; 2021 Dec; 29(6):913-919. PubMed ID: 33357155
[TBL] [Abstract][Full Text] [Related]
55. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
56. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
57. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
Rai V; Kumar P
Neurol Sci; 2018 Dec; 39(12):2033-2041. PubMed ID: 30267335
[TBL] [Abstract][Full Text] [Related]
58. Association of Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms with Mild Cognitive Impairment Susceptibility: A Systematic Review and Meta-Analysis.
Sun J; Jiang X; Zhao M; Ma L; Pei H; Liu N; Li H
Behav Neurol; 2021; 2021():2962792. PubMed ID: 34580600
[TBL] [Abstract][Full Text] [Related]
59. Genetic association between methylenetetrahydrofolate reductase gene polymorphism and risk of osteonecrosis of the femoral head.
Chai W; Zhang Z; Ni M; Geng P; Lian Z; Zhang G; Shi LL; Chen J
Biomed Res Int; 2015; 2015():196495. PubMed ID: 25688352
[TBL] [Abstract][Full Text] [Related]
60. The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.
Stoccoro A; Tannorella P; Salluzzo MG; Ferri R; Romano C; Nacmias B; Siciliano G; Migliore L; Coppedè F
J Alzheimers Dis; 2017; 56(4):1451-1457. PubMed ID: 28211809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
